E.G7-OVA In Vitro Anti-Tumor Efficacy Assay

This assay is to provide E.G7-OVA-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

E.G7-OVA

Mouse

E.G7-OVA [derivative of EL4] T lymphoblasts are T lymphoblasts derived in 1988 from the C57BL/6 (H-2 b) mouse lymphoma cell line EL4. E.G7-OVA [derivative of EL4] is a model system for studying major histocompatibility complex (MHC) class I restricted responses of cytotoxic T lymphocytes in mice.

Lymphoma

Oncology

In Vitro Anti-Tumor Efficacy Assay

Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.

Oncology Efficacy Assays